Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro

One of the most promising viral targets in current hepatitis B virus (HBV) drug development is the core protein due to its multiple roles in the viral life cycle. Here we investigated the differences in the mode of action and antiviral activity of representatives of six different capsid assembly mod...

Full description

Saved in:
Bibliographic Details
Main Authors: Corcuera, Angelica (Author) , Stolle, Katharina (Author) , Hillmer, Stefan (Author) , Seitz, Stefan (Author) , Lee, Ji Young (Author) , Bartenschlager, Ralf (Author) , Birkmann, Alexander (Author) , Urban, Andreas (Author)
Format: Article (Journal)
Language:English
Published: [October 2018]
In: Antiviral research
Year: 2018, Volume: 158, Pages: 135-142
ISSN:1872-9096
DOI:10.1016/j.antiviral.2018.07.011
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.antiviral.2018.07.011
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0166354218303292
Get full text
Author Notes:Angelica Corcuera, Katharina Stolle, Stefan Hillmer, Stefan Seitz, Ji-Young Lee, Ralf Bartenschlager, Alexander Birkmann, Andreas Urban
Search Result 1

Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro by Corcuera, Angelica (Author) , Hillmer, Stefan (Author) , Seitz, Stefan (Author) , Lee, Ji Young (Author) , Bartenschlager, Ralf (Author) ,

Elsevier Science 2018 Universitätsbibliothek Heidelberg 2018

Get full text
Article (Journal) Online Resource